Peripheral Arterial Disease Trial, Recruiting NCT05457738 Sponsor: CHU de Reims Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT05457738
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been experiencing leg pain or cramping when walking (claudication) due to peripheral artery disease (PAD) for more than 3 months
  • People whose blood pressure measurement in the affected leg is below a certain level, indicating reduced blood flow (a systolic pressure index below 0.90) (confirm with trial site)
  • People who have no other health condition that limits their ability to walk, apart from PAD
  • People who have had an ultrasound scan of the arteries in their legs that shows a blockage or narrowing
  • People who have not had a heart attack in the last 6 months
  • People who do not have a heart condition that requires surgery
  • People who do not have chest pain (angina)
  • People who are covered by a social security or health insurance system (confirm with trial site)
  • People who have given their free and written agreement to participate

Who may not be able to join:

  • People who have not had an ultrasound scan of the arteries in their legs
  • People who have had a heart attack within the last 6 months
  • People who experience chest pain (angina)
  • People who have a serious narrowing of the main heart valve (aortic valve stenosis) that is causing symptoms
  • People who have another condition, separate from PAD, that limits their ability to walk

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 26 78 46 60

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
19 April 2024
Est. completion
19 May 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

maximal walking distance on treadmill test; maximal walking distance on treadmill test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov